Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avik Maji

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
South Asian Journal of Cancer|December 7, 2019
Barriers and explanatory mechanisms in diagnostic delay in four cancers - A health-care disparity?Abhishek Basu, Debjit Ghosh, Bidyut Mandal, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|September 26, 2025
Unveiling the Anti-cancer Potential of Oxadiazole Derivatives: A Comprehensive Exploration of Structure-Activity Relationships and Chemico-Biological InsightsSai Satyaprakash Mishra, Ajeya Samanta, Abhik Paul, et al.
Bioorganic & Medicinal Chemistry|August 1, 2021
Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitorsAbhik Paul, Arnab Sarkar, Sanjukta Saha, et al.
Life Sciences|February 28, 2021
Understanding stem cells and its pivotal role in regenerative medicineArnab Sarkar, Sanjukta Saha, Abhik Paul, et al.
European Journal of Pharmacology|February 15, 2023
Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancerArnab Sarkar, Abhik Paul, Tanmoy Banerjee, et al.
European Journal of Medicinal Chemistry|December 1, 2023
Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationshipsAbhik Paul, Sourin Nahar, Pankaj Nahata, et al.
Molecular Cancer|February 22, 2023
Lung cancer immunotherapy: progress, pitfalls, and promisesAritraa Lahiri, Avik Maji, Pravin D Potdar, et al.
RSC Medicinal Chemistry|September 23, 2024
Synthesis and antiproliferative potency of 1,3,4-thiadiazole and 1,3-thiazolidine-4-one based new binary heterocyclic molecules: <i>in vitro</i> cell-based anticancer studiesAvik Maji, Ambati Himaja, Sripathi Nikhitha, et al.
Biochemical Pharmacology|February 5, 2024
Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeuticsAvik Maji, Abhik Paul, Arnab Sarkar, et al.
Future Medicinal Chemistry|August 30, 2025
Synthesis, crystal structure, and <i>in vitro</i> evaluation of newer 2,4-thiazolidinedione hybrids as α-glucosidase inhibitorsAbhik Paul, Arnab Sarkar, Sai Satyaprakash Mishra, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
South Asian Journal of Cancer|December 7, 2019
Barriers and explanatory mechanisms in diagnostic delay in four cancers - A health-care disparity?Abhishek Basu, Debjit Ghosh, Bidyut Mandal, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|September 26, 2025
Unveiling the Anti-cancer Potential of Oxadiazole Derivatives: A Comprehensive Exploration of Structure-Activity Relationships and Chemico-Biological InsightsSai Satyaprakash Mishra, Ajeya Samanta, Abhik Paul, et al.
Bioorganic & Medicinal Chemistry|August 1, 2021
Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitorsAbhik Paul, Arnab Sarkar, Sanjukta Saha, et al.
Life Sciences|February 28, 2021
Understanding stem cells and its pivotal role in regenerative medicineArnab Sarkar, Sanjukta Saha, Abhik Paul, et al.
European Journal of Pharmacology|February 15, 2023
Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancerArnab Sarkar, Abhik Paul, Tanmoy Banerjee, et al.
European Journal of Medicinal Chemistry|December 1, 2023
Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationshipsAbhik Paul, Sourin Nahar, Pankaj Nahata, et al.
Molecular Cancer|February 22, 2023
Lung cancer immunotherapy: progress, pitfalls, and promisesAritraa Lahiri, Avik Maji, Pravin D Potdar, et al.
RSC Medicinal Chemistry|September 23, 2024
Synthesis and antiproliferative potency of 1,3,4-thiadiazole and 1,3-thiazolidine-4-one based new binary heterocyclic molecules: <i>in vitro</i> cell-based anticancer studiesAvik Maji, Ambati Himaja, Sripathi Nikhitha, et al.
Biochemical Pharmacology|February 5, 2024
Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeuticsAvik Maji, Abhik Paul, Arnab Sarkar, et al.
Future Medicinal Chemistry|August 30, 2025
Synthesis, crystal structure, and <i>in vitro</i> evaluation of newer 2,4-thiazolidinedione hybrids as α-glucosidase inhibitorsAbhik Paul, Arnab Sarkar, Sai Satyaprakash Mishra, et al.
Pageof 1